AR and Familial prostate cancer: The Notch pathway can also be activated to inhibit achaete‐scute family basic helix‐loop‐helix (BHLH) transcription factor 1 (ASCL1) expression for treating androgen receptor‐active prostate cancer (ARPC) and neuroendocrine prostate cancer (NEPC).